ArticleiScience2026
Mitochondrial dysfunction activates ADAMTS-5 expression via mt-dsRNA-PKR-Spi-1 axis in osteoarthritic chondrocytes.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) involves cartilage degradation by ADAMTS-5, but how ADAMTS-5 expression is activated remains unclear. A recent study found that mitochondrial double-strand RNA (mt-dsRNA) and its leakage into the cytosol activate protein kinase R (PKR), which facilitates OA progression. However, the mechanisms are yet to be clarified. In this study, we focused on how mt-dsRNAs and PKR signaling activate ADAMTS-5 expression in chondrocytes undergoing mitochondrial dysfunction. Our findings revealed that mitochondrial dysfunction triggered the leakage of mt-dsRNAs into the cytosol. These mt-dsRNAs activated PKR to initiate Spi-1-dependent ADAMTS-5 transcription. Increased levels of mt-dsRNAs and PKR activation in the cartilage from OA patients and mice corroborate our findings. More importantly, PKR conditional knockout from articular chondrocytes alleviates the pathological phenotypes of OA mice. Our research offers a deep understanding of OA driven by mitochondrial dysfunction in chondrocytes and proposes mt-dsRNAs-PKR as potential targets for OA drugs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.